5th Annual Perinatal Stem Cell Society Congress: 2-Day Event (Utah, United States - February 28, 2019 March 1, 2019) - ResearchAndMarkets.com

February 1, 2019

DUBLIN--(BUSINESS WIRE)--Feb 1, 2019--The “5th Annual Perinatal Stem Cell Society Congress” conference has been added to ResearchAndMarkets.com’s offering.

The field of regenerative medicine is expanding exponentially and the use of perinatal tissue derived products is a major driving force behind this growth.

Perinatal tissue derived products are regulated like all human cells and tissue products HCT/Ps are regulated by the FDA in tiered risk-based approach and are either regulated under section 361 of the Pubic Health Service Act (PHS Act) or the product is treated as a drug and regulated under section 351of the PHS Act. In addition to the PHS Act the FDA has published a series of Guidance Documents to provide further clarification on how the FDA plans to interpret the law in regards to HCT/Ps.

It is the view of the organiser, that the current regulation paradigms for HCT/Ps are not adequate to address the revolutionary growth in the use of perinatal derived tissue and stem cell products taking place in the United States and throughout the world. As such, they feel that it is incumbent on the industry and clinicians working in the field to self regulate in order to provide only the safest and most efficacious products to the public.

As the organiser’s are comprised of many of the world’s leading researchers and clinicians, they have decided to form a working group of industry representatives and society members to develop voluntary guidelines for manufacturers producing 361 regulated perinatal derived tissue and stem cell products.

Benefits of Registration:

Access to leading-edge research from pioneers across the field Networking opportunities to cultivate relationships with relevant and engaged colleagues and organizations A unique opportunity to learn from the leading clinicians utilizing cellular therapies in their practices

Companies Featured

Auxocell Biolife Biospherix Boston Biolife Mediware Monash University Nordmark Plass Wake Forest


Thursday, February 28

7:00 - 8:00 Breakfast in Exhibit Hall

8:00 - 8:30

Jaideep Banerjee, PhD

Advancement of Placental Tissue Preservation and Clinical Outcomes for Management of Chronic Wounds

8:30 - 9:00

Doug Schmid, PhD

Wharton’s Jelly Potential In Regenerative Medicine

9:00 - 9:30

Ornella Parolini, PHD

Immunomodulation of Amniotic Cells and Their Derivatives At the Basis of Their Beneficial Effects In Regenerative Medicine

9:30 - 10:00

Tomasz Baran MD, MBA

FamiCord’s clinical experience with WJ derived product application in various clinical areas.


10:00 - 10:30 Exhibit Hall Break


10:30 - 11:00

Neil Riordan, PA, PhD

Results From Panama Clinical Trials Using Umbilical Cord MSCs: MultioleSclerosis and Autism

11:00 - 12:00

Joanne Kurtzberg, MD

Extending Cord Blood to Regenerative Therapies for the Brain


12:00 - 1:00 Lunch


1:00 - 1:30

Rouzbeh R. Taghizadeh, PhD

Umbilical Cord Tissue Processing Technologies for Perinatal MSC Banking

1:30 - 2:00

Sam Fagg

Translating In Utero to In Vitro: A Novel Amniotic Co-Culture System Yields An Enhanced Secretome With Unique Properties

2:00 - 2:30

Ramon Coronado, MSc, PhD

Therapeutic Effects of Various Perinatal Cells On a Humanized Graft-Versus-Host-Disease (GvHD) Mice Model

2:30 - 3:00

James L. Sherley, MD, PhD

Putting Clothes on the Emperor: A First Technology for Specific Counting of Adult Tissue Stem Cells


3:00 - 3:30 Exhibit Hall Break


3:30 - 4:00 Thursday

Stephen Strom, PhD

Perinatal Stem Cells to Treat Liver Disease

4:00 - 4:30 Thursday

Lou Barnes, B.S.Ed., MBA, CTBS

Birth Tissue Regulatory and Standards Environment

4:30 - 5:00 Thursday

Mike Druckman

Regulatory Questions All 361 Companies Should Understand


Networking Cocktail Reception & Dinner


Friday, March 1

7:00 - 8:00 Breakfast in Exhibit Hall


8:00 - 8:30

Susana Cantero Peral

Cord Blood Derived Mononuclear Cells For the Treatment of Hypoplastic Left Heart Syndrome

9:00 - 9:30

Melissa Suter, PhD

Trophoblast Purification and Characterization In Vitro

9:30 - 10:00

Timothy Ganey, PhD

Quantification of Exosome Product


10:00 - 10:30 Exhibit Hall Break


10:30 - 11:00

Rebeca Lim, PhD

Exosome Therapy for Bronchopulmonary Dysplasia - Are We Ready for Cell-free Regenerative Medicine?

11:00 - 11:30

Oula Khoury

Perinatal Cell Therapy For the Treatment of Inflammatory Lung Diseases

11:30 - 12:00

Ramkumar Menon, MD, PhD

Senescent Amniochorionic Membranes Propagates Signals of Parturition through Extracellular Vesicles


12:00 - 1:00 Lunch


1:00 - 1:30

Niranjan Bhattacharya, PhD

Amnion for Burns

1:30 - 2:00

Vinesh Mandot

AmchoPlast - Wound Care from the Womb

2:00 - 2:30

Francisco J. Nicols, PhD

Understanding the molecular signaling behind Amniotic Membrane healing effect on difficult wounds: chronic wounds and diabetic foot ulcers.

2:30 - 3:00

Jeremy J. Lim, PhD

Biological properties of dehydrated human amnion/chorion membrane and umbilical cord allografts for soft tissue healing.


3:00 - 3:30 Exhibit Hall Break


3:30 - 4:00

Sean Murphy, PhD

Amnion Membrane-Derived Cells and Materials for Skin Wound Treatment

4:00 - 4:30 Company Presentations Predictive Biotech/XcellBiologics/BioSpherix

4:30 - 5:00 Company Presentations IPLASS/TBD/TBD

5:00 - 5:30 Industry Issues WorkShop

For more information about this conference visit https://www.researchandmarkets.com/research/mjqrjm/5th_annual?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190201005141/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Women’s Health,Stem Cells



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/01/2019 04:21 AM/DISC: 02/01/2019 04:21 AM


Update hourly